// App-Quantinova.ai

303.0 : Real-world outcomes among patients (pts) treated with gemcitabine (GEM)-based therapy post-FOLFIRINOX (FFOX) failure in advanced pancreatic cancer (APC).

Researchers

Presenter

  • Erica S Tsang

Principal Investigators

  • Jennifer L. Spratlin

  • Winson Y. Cheung

  • Christina Kim

  • Shiying Kong

  • Yuan Xu

  • Sharlene Gill

Medical Centers

  • BC Cancer Agency, Vancouver, BC, Canada

  • Cross Cancer Institute, Edmonton, AB, Canada

  • BC Cancer Agency, Vancouver, BC, Canada

  • Cancer Care Manitoba, Winnipeg, MB, Canada

  • University of Calgary, Calgary, AB, Canada

  • Tom Baker Cancer Center, Calgary, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreato-biliary malignancies

Biomarkers

  • Adenomatous Polyposis Coli

Drug/Treatment

  • Gemcitabine

  • FOLFIRINOX

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved